Novo Nordisk wins US approval for Wegovy pill launch

Health

EnglishEnglish

Novo Nordisk wins US approval for Wegovy pill launch

Novo Nordisk just scored a big win with US approval for their Wegovy pill, set to hit the shelves in January! Priced at $149 a month (or just $25 with insurance magic), this little pill promises a 16.6% body-weight loss. With a strategy to reach more folks and fend off competition, Novo is ready to shake up the obesity game!

|